Inventor · disambiguated record
Steven David Stone
Also filed as: STONE STEVEN D · STONE STEVEN DAVID
2 granted patents·6 pending applications·7 citations·filing 2021–2023
47Inventor score
Files withVERTEX PHARMA8
Top patents by PatentIndex Score
8 records- 0192US11866446B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2021·Granted Jan 9, 2024·7 cites·55 claims
- 0271US12421249B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2023·Granted Sep 23, 2025·0 cites·23 claims
- 0360US2025136612A14',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran] derivatives as inhibitors of apol1 and methods of using sameVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 0459US2025171459A12-methyl-4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran] derivatives as inhibitors of apol1 and methods of using sameVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 0557US2025163021A12-methyl-4-phenylpiperidin-4-ol derivatives as inhibitors of apol1 and methods of using sameVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 0657US2023203000A1Inhibitors of apol1 and methods of using sameVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 0756US2025084094A1Spirocyclic inhibitors of apol1 and methods of using sameVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 0853US2023159504A17- or 8-hydroxy-isoquinoline and 7- or 8-hydroxy-quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (aatd)VERTEX PHARMA·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Steven David Stone files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →